Jim Cramer recently discussed Kimberly-Clark Corporation (NASDAQ:KMB) and its acquisition of Kenvue for $48.7 billion. Cramer praised the deal, highlighting the strategic strengths and opportunities it presents for Kimberly-Clark in different global regions, particularly in China and Europe. The deal also addresses concerns regarding Tylenol and talc-related lawsuits in Europe.

Read more at Yahoo Finance: Jim Cramer Just Couldn’t Help Himself When Talking About Kimberly-Clark (KMB)’s Kenvue Acquisition